Sign in

CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(800) 466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. DEFA14A Proxy Proxy Materials
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. DEFA14A Proxy Proxy Materials
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. EFFECT Other Notice of Effectiveness
  6. EFFECT Other Notice of Effectiveness
  7. DRS Other Draft Registration Statement
  8. DEFA14A Proxy Proxy Materials
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. EFFECT Other Notice of Effectiveness
  12. CERT Other Certification
  13. 8-A12B Other Registration of Securities
  14. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  15. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  16. DRS Other Draft Registration Statement
  17. D Other Notice of Sales of Unregistered Securities

Page 2 of 2 · 37 filings